These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 17720532)
1. Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome. Park J; Yang EJ; Yoon JH; Chung KC Mol Cell Neurosci; 2007 Oct; 36(2):270-9. PubMed ID: 17720532 [TBL] [Abstract][Full Text] [Related]
2. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339 [TBL] [Abstract][Full Text] [Related]
3. Dual-specificity tyrosine-phosphorylated and regulated kinase 1A (DYRK1A) interacts with the phytanoyl-CoA alpha-hydroxylase associated protein 1 (PAHX-AP1), a brain specific protein. Bescond M; Rahmani Z Int J Biochem Cell Biol; 2005 Apr; 37(4):775-83. PubMed ID: 15694837 [TBL] [Abstract][Full Text] [Related]
4. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644 [TBL] [Abstract][Full Text] [Related]
5. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279 [TBL] [Abstract][Full Text] [Related]
6. Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease. Ryu YS; Park SY; Jung MS; Yoon SH; Kwen MY; Lee SY; Choi SH; Radnaabazar C; Kim MK; Kim H; Kim K; Song WJ; Chung SH J Neurochem; 2010 Nov; 115(3):574-84. PubMed ID: 20456003 [TBL] [Abstract][Full Text] [Related]
7. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice. Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917 [TBL] [Abstract][Full Text] [Related]
8. Regulation of the proapoptotic activity of huntingtin interacting protein 1 by Dyrk1 and caspase-3 in hippocampal neuroprogenitor cells. Kang JE; Choi SA; Park JB; Chung KC J Neurosci Res; 2005 Jul; 81(1):62-72. PubMed ID: 15906374 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11α. Park JH; Jung MS; Kim YS; Song WJ; Chung SH J Neurochem; 2012 Sep; 122(5):1081-91. PubMed ID: 22765017 [TBL] [Abstract][Full Text] [Related]
10. The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. Laguna A; Aranda S; Barallobre MJ; Barhoum R; Fernández E; Fotaki V; Delabar JM; de la Luna S; de la Villa P; Arbonés ML Dev Cell; 2008 Dec; 15(6):841-53. PubMed ID: 19081073 [TBL] [Abstract][Full Text] [Related]
11. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes. García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555 [TBL] [Abstract][Full Text] [Related]
12. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development. Hämmerle B; Elizalde C; Tejedor FJ Eur J Neurosci; 2008 Mar; 27(5):1061-74. PubMed ID: 18364031 [TBL] [Abstract][Full Text] [Related]
13. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro. Coutadeur S; Benyamine H; Delalonde L; de Oliveira C; Leblond B; Foucourt A; Besson T; Casagrande AS; Taverne T; Girard A; Pando MP; Désiré L J Neurochem; 2015 May; 133(3):440-51. PubMed ID: 25556849 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome. Hijazi M; Fillat C; Medina JM; Velasco A Exp Neurol; 2013 Jan; 239():229-34. PubMed ID: 23124096 [TBL] [Abstract][Full Text] [Related]
15. Cell type- and brain structure-specific patterns of distribution of minibrain kinase in human brain. Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Dowjat K; Silverman WP; Reisberg B; DeLeon M; Wisniewski T; Adayev T; Chen-Hwang MC; Hwang YW Brain Res; 2004 Jun; 1010(1-2):69-80. PubMed ID: 15126119 [TBL] [Abstract][Full Text] [Related]
17. Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation. Göckler N; Jofre G; Papadopoulos C; Soppa U; Tejedor FJ; Becker W FEBS J; 2009 Nov; 276(21):6324-37. PubMed ID: 19796173 [TBL] [Abstract][Full Text] [Related]
18. Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation. Kim EJ; Sung JY; Lee HJ; Rhim H; Hasegawa M; Iwatsubo T; Min do S; Kim J; Paik SR; Chung KC J Biol Chem; 2006 Nov; 281(44):33250-7. PubMed ID: 16959772 [TBL] [Abstract][Full Text] [Related]
19. Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals. Kida E; Walus M; Jarząbek K; Palminiello S; Albertini G; Rabe A; Hwang YW; Golabek AA Neuroscience; 2011 Nov; 195():112-27. PubMed ID: 21878370 [TBL] [Abstract][Full Text] [Related]
20. DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine. Seifert A; Allan LA; Clarke PR FEBS J; 2008 Dec; 275(24):6268-80. PubMed ID: 19016842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]